Beckman Coulter ClearLLab Reagents - Taiwan Registration 5ab3a7aa48bd9f66cbcf5db117ba68b1
Access comprehensive regulatory information for Beckman Coulter ClearLLab Reagents in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5ab3a7aa48bd9f66cbcf5db117ba68b1 and manufactured by Beckman Coulter, Inc.. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
5ab3a7aa48bd9f66cbcf5db117ba68b1
Ministry of Health Medical Device Import No. 031346
DHA05603134602
Product Details
This product is an in vitro diagnostic reagent that can identify various cell populations by immunotyping on the FC500 flow cytometer. This product is designed to assist in the differential diagnosis of types of hematologic abnormalities in patients with or suspected hematopoietic cell carcinogenesis, including chronic leukemia, acute leukemia, non-Hodgkin lymphoma, myeloma, myelodysplastic syndrome (MDS), and/or myeloproliferative neoplasms (MPN). This reagent can be used for immunotyping of peripheral whole blood (K2EDTA, ACD, or Heparin), bone marrow (K2EDTA, ACD, or Heparin), and lymph node samples.
B Hematology and pathology devices
B5220 automatically differentiates cell counters
Imported from abroad
Dates and Status
Aug 03, 2018
Aug 03, 2028